Free tool
FAERS Monitor: Pretomanid
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 212862 or its brand name (Pretomanid, Pretomanid). Reports on generic versions are filed under their own applications.
Reports
760
Serious
739
97% of reports
Hospitalization
166
Death reported
294
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death126
- anaemia84
- neuropathy peripheral81
- off label use68
- nausea57
- electrocardiogram qt prolonged53
- decreased appetite28
- acute kidney injury27
- toxicity to various agents26
- alanine aminotransferase increased23
- aspartate aminotransferase increased22
- hepatotoxicity22
- vomiting22
- asthenia20
- thrombocytopenia17
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 4 |
| 2019 | 13 |
| 2020 | 9 |
| 2021 | 4 |
| 2022 | 69 |
| 2023 | 126 |
| 2024 | 173 |
| 2025 | 192 |
| 2026 | 165 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,399 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| electrocardiogram qt prolongedSignal | 53 | 40.8 | 31.5 | 2,021 |
| hepatotoxicitySignal | 22 | 27.4 | 18.1 | 533 |
| neuropathy peripheralSignal | 81 | 23.6 | 19.2 | 1,736 |
| anaemiaSignal | 84 | 12.2 | 10.0 | 859 |
| aspartate aminotransferase increasedSignal | 22 | 11.5 | 7.6 | 200 |
| alanine aminotransferase increasedSignal | 23 | 10.4 | 6.9 | 186 |
| acute kidney injurySignal | 27 | 4.9 | 3.4 | 80 |
| toxicity to various agentsSignal | 26 | 4.3 | 2.9 | 62 |
| thrombocytopeniaSignal | 17 | 4.2 | 2.6 | 39 |
| deathSignal | 126 | 4.0 | 3.5 | 298 |
| decreased appetiteSignal | 28 | 3.3 | 2.3 | 44 |
| off label useSignal | 68 | 2.1 | 1.7 | 42 |
| nausea | 57 | 2.0 | 1.6 | 28 |
| asthenia | 20 | 1.5 | 1.0 | 3 |
| vomiting | 22 | 1.3 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.